Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

Transcription profiling of rat Mat-Lylu cell line compared to G cell line

ABSTRACT: we analyzed the gene expression profiles of Mat-Lylu cell lines (in duplicate) compared to G cell lines (in duplicate) using Affymetrix tools and dChip software. The objective was to find metastasis-associated genes in prostate cancer, using this in vitro model. Experiment Overall Design: we used Mat_lylu cell line samples (duplicates) as the Experiment group and G cell line samples (duplicates) as control group.

ORGANISM(S): Rattus norvegicus

SUBMITTER: Ismael Reyes

PROVIDER: E-GEOD-7703 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Publications

DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.

Reyes Ismail I Tiwari Raj R Geliebter Jan J Reyes Niradiz N

Biomedica : revista del Instituto Nacional de Salud 20070601 2

<h4>Introduction</h4>The molecular and cellular mechanisms involved in prostate cancer progression towards a hormone-independent and highly invasive, metastatic phenotype, are not well understood. Cell lines with different metastatic potential, when analyzed by microarray techniques, offer valuable tools for identifying genes associated with the metastatic phenotype.<h4>Objectives</h4>Gene expression profiles were compared for two rat prostate cancer cell lines with differing metastatic abilitie ...[more]

PMID: 17713630

Similar Datasets

Project description:Hass2017-PanRTK model for single cell line The model structure comprises heterodimerization and receptor trafficking as described in detail in the article below. For ligand input, set a respective event. The illustrated event sets the EGF concentration to 2.5 nMol in the model file. This model is described in the article: Predicting ligand-dependent tumors from multi-dimensional signaling features. Hass H, Masson K, Wohlgemuth S, Paragas V, Allen JE, Sevecka M, Pace E, Timmer J, Stelling J, MacBeath G, Schoeberl B, Raue A. NPJ Syst Biol Appl 2017; 3: 27 Abstract: Targeted therapies have shown significant patient benefit in about 5-10% of solid tumors that are addicted to a single oncogene. Here, we explore the idea of ligand addiction as a driver of tumor growth. High ligand levels in tumors have been shown to be associated with impaired patient survival, but targeted therapies have not yet shown great benefit in unselected patient populations. Using an approach of applying Bagged Decision Trees (BDT) to high-dimensional signaling features derived from a computational model, we can predict ligand dependent proliferation across a set of 58 cell lines. This mechanistic, multi-pathway model that features receptor heterodimerization, was trained on seven cancer cell lines and can predict signaling across two independent cell lines by adjusting only the receptor expression levels for each cell line. Interestingly, for patient samples the predicted tumor growth response correlates with high growth factor expression in the tumor microenvironment, which argues for a co-evolution of both factors in vivo. This model is hosted on BioModels Database and identified by: MODEL1708210000. To cite BioModels Database, please use: Chelliah V et al. BioModels: ten-year anniversary. Nucl. Acids Res. 2015, 43(Database issue):D542-8. To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.

Dataset Information

Transcription profiling of rat Mat-Lylu cell line compared to G cell line

Publications

DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets